Skip to content

Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma

Recurrence ad Survival After Robotic Versus Laparoscopic Liver Resection in Very-early to Early (BCLC 0-A) Hepatocellular Carcinoma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06496113
Enrollment
196
Registered
2024-07-11
Start date
2014-01-31
Completion date
2024-06-30
Last updated
2024-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

The objective of the study is to investigate the long-term outcomes of minimally invasive liver surgery (robotic vs laparoscopic) for hepatocellular carcinoma patients of stage BCLC 0-A. Data from two tertiary centers for liver surgery will be retrospectively reviewed. Patients will be divided in two cohorts (robot; laparoscopy). The primary endpoint will be recurrence-free and overall survival; secondary endpoints were incidence, pattern, and treatment of recurrences.

Interventions

Patients underwent liver resection either by robotic or laparoscopic approach

Sponsors

Ente Ospedaliero Cantonale, Bellinzona
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing robotic and laparoscopic resections * Histology-confirmed HCC of stage BCLC 0-A * Preserved liver function (Child score A-B) * Patients \>18 years old

Exclusion criteria

* Hand-assisted procedures * Non-elective surgery * Intraoperative switch to locoregional therapies (like radiofrequency or microwave ablation) * Non-histologically confirmed HCC * Mixed hepato-cholangiocarcinoma.

Design outcomes

Primary

MeasureTime frameDescription
Recurrence-free survivalFrom the date of liver resection until the first documented HCC progression on follow-up imaging, assessed up to 116 months. The Minimum follow-up accepted was of 3 months postoperatively.Recurrence was dated at the first HCC detection on follow-up imaging.
Overall survivalFrom the date of liver resection until the date of death for any cause or the last follow-up available whichever came first, assessed up to 116 months. The Minimum follow-up accepted was of 3 months postoperatively.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026